Comprehensive Genetic Screening for Informed Healthcare Decisions

Understanding the different types of genetic tests helps you know which test is appropriate for your situation. Each test serves specific purposes and examines different aspects of your genetic material.

Carrier Screening

Carrier screening identifies whether you carry a gene mutation for recessive genetic disorders. Carriers typically don’t have symptoms but can pass the mutation to their children.

Common Conditions Screened:

• Thalassemia (blood disorder)
• Sickle cell disease
• Cystic fibrosis
• Spinal muscular atrophy (SMA)
• Fragile X syndrome
• Tay-Sachs disease

How It Works:

Carrier screening examines specific genes known to cause inherited conditions. If both partners carry mutations in the same gene, each pregnancy has a 25% risk of the child being affected with the condition.

Who Benefits:

• Couples planning pregnancy
• Individuals with family history of genetic conditions
• Ethnic groups with higher carrier rates for specific disorders
• Anyone seeking comprehensive reproductive planning

Carrier screening is ideally performed before pregnancy, allowing couples to understand risks and explore options including IVF with preimplantation genetic testing, prenatal diagnosis, or using donor eggs/sperm.

Preimplantation Genetic Testing (PGT)

Preimplantation genetic testing examines embryos created through IVF before transfer to the uterus. This advanced testing identifies genetic abnormalities, allowing selection of healthy embryos.

Types of PGT:

PGT-A (Aneuploidy Screening)

• Screens for abnormal chromosome numbers
• Identifies conditions like Down syndrome, Turner syndrome, or Klinefelter syndrome
• Improves IVF success rates by selecting chromosomally normal embryos
• Reduces miscarriage risk

PGT-M (Monogenic Disorders)

• Tests for specific single-gene disorders
• Used when parents carry mutations for conditions like cystic fibrosis, sickle cell disease, or Huntington’s disease
• Prevents transmission of known genetic conditions
• Enables healthy pregnancy without affected children

PGT-SR (Structural Rearrangements)

• Identifies chromosomal structural problems
• Used when parents have balanced translocations or inversions
• Reduces miscarriage risk from unbalanced chromosomal arrangements
• Improves chances of successful pregnancy

The PGT Process:

Embryos are biopsied at day 5 or 6 of development, removing a few cells for genetic analysis while the embryo continues developing. Results typically take 1-2 weeks. Only embryos without detected genetic abnormalities are selected for transfer.

Benefits:

• Significantly reduces risk of genetic disease in offspring
• Improves IVF success rates
• Decreases miscarriage rates
• Reduces need for difficult pregnancy decisions
• Provides peace of mind

Prenatal Genetic Testing

Prenatal testing examines the fetus during pregnancy to detect genetic abnormalities or chromosomal conditions.

Non-Invasive Prenatal Testing (NIPT)

• Blood test analyzing fetal DNA in mother’s bloodstream
• Performed from 10 weeks of pregnancy
• Screens for Down syndrome, Edwards syndrome, Patau syndrome
• Highly accurate with low false-positive rates
• No risk to pregnancy

Invasive Prenatal Testing:

Chorionic Villus Sampling (CVS)

• Performed at 11-14 weeks of pregnancy
• Samples placental tissue for genetic analysis
• Diagnoses chromosomal abnormalities and single-gene disorders
• Small risk of miscarriage (0.5-1%)

Amniocentesis

• Performed at 15-20 weeks of pregnancy
• Samples amniotic fluid containing fetal cells
• Provides comprehensive chromosomal and genetic information
• Small risk of miscarriage (0.1-0.5%)

Prenatal testing helps parents understand fetal health, prepare for special medical needs, or make informed decisions about pregnancy continuation.

Diagnostic Genetic Testing

Diagnostic testing confirms or rules out suspected genetic conditions when symptoms are present or family history suggests specific disorders.

Used For:

• Confirming clinical diagnosis
• Explaining unexplained symptoms
• Investigating developmental delays
• Evaluating intellectual disabilities
• Assessing recurrent miscarriages

Common Diagnostic Tests:

Karyotyping

• Examines chromosome number and structure
• Identifies large chromosomal abnormalities
• Diagnoses conditions like Down syndrome or Turner syndrome

Chromosomal Microarray

• Detects small chromosomal deletions or duplications
• More detailed than karyotyping
• Identifies causes of developmental delays

Single Gene Testing

• Examines specific genes for known mutations
• Confirms suspected conditions like hemophilia or muscular dystrophy

Whole Exome Sequencing (WES)

• Analyzes all protein-coding genes
• Used when condition cause is unknown
• Identifies rare or novel genetic variants

Predictive and Presymptomatic Testing

This testing identifies genetic mutations that increase disease risk before symptoms appear.

Cancer Susceptibility Testing:

• BRCA1/BRCA2 mutations (breast and ovarian cancer risk)
• Lynch syndrome genes (colorectal cancer risk)
• Other hereditary cancer syndromes

Adult-Onset Conditions:

• Huntington’s disease
• Familial Alzheimer’s disease
• Hereditary heart conditions
• Polycystic kidney disease

Benefits:

• Enables enhanced surveillance and early detection
• Guides preventive measures (prophylactic surgery, medications)
• Informs family planning decisions
• Provides psychological preparation

Considerations:

Predictive testing requires careful counseling as results can have significant psychological and social implications. Not everyone at risk chooses testing, and this decision is deeply personal.

Pharmacogenomic Testing

Pharmacogenomic testing examines how your genes affect medication response, enabling personalized treatment approaches.

Applications:

• Predicting drug effectiveness
• Identifying risk of adverse reactions
• Optimizing medication dosing
• Selecting most appropriate medications

Commonly Tested Areas:

• Cardiovascular medications
• Cancer treatments
• Mental health medications
• Pain management drugs

This emerging field of personalized medicine improves treatment outcomes and reduces trial-and-error in medication selection.